INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 179 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,559,523 | +52.5% | 29,939 | +85.4% | 0.00% | +50.0% |
| Q2 2023 | $1,022,365 | +40.4% | 16,146 | +20.1% | 0.00% | 0.0% |
| Q1 2023 | $728,263 | -27.5% | 13,449 | -29.2% | 0.00% | 0.0% |
| Q4 2022 | $1,005,004 | +6.1% | 18,991 | -6.7% | 0.00% | 0.0% |
| Q3 2022 | $947,000 | -28.0% | 20,345 | -11.7% | 0.00% | -33.3% |
| Q2 2022 | $1,316,000 | +119.0% | 23,047 | +134.6% | 0.00% | +200.0% |
| Q1 2022 | $601,000 | +34.8% | 9,825 | +15.3% | 0.00% | 0.0% |
| Q4 2021 | $446,000 | +40.3% | 8,522 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $318,000 | -8.6% | 8,522 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $348,000 | -44.2% | 8,522 | -53.7% | 0.00% | 0.0% |
| Q1 2021 | $624,000 | -40.2% | 18,394 | -44.0% | 0.00% | -50.0% |
| Q4 2020 | $1,044,000 | -21.2% | 32,835 | -36.4% | 0.00% | 0.0% |
| Q3 2020 | $1,325,000 | -16.7% | 51,648 | -16.6% | 0.00% | -33.3% |
| Q2 2020 | $1,590,000 | +68.8% | 61,930 | +1.0% | 0.00% | +50.0% |
| Q1 2020 | $942,000 | +316.8% | 61,314 | +209.1% | 0.00% | – |
| Q4 2018 | $226,000 | -58.5% | 19,837 | -21.0% | 0.00% | -100.0% |
| Q3 2018 | $545,000 | +23.6% | 25,112 | +0.6% | 0.00% | – |
| Q2 2018 | $441,000 | +53.7% | 24,966 | +32.3% | 0.00% | – |
| Q3 2016 | $287,000 | -56.9% | 18,864 | +9.9% | 0.00% | -100.0% |
| Q2 2016 | $666,000 | +15.0% | 17,162 | -17.5% | 0.00% | 0.0% |
| Q1 2016 | $579,000 | -70.8% | 20,814 | -43.5% | 0.00% | -66.7% |
| Q4 2015 | $1,982,000 | +16.7% | 36,856 | -13.1% | 0.00% | 0.0% |
| Q3 2015 | $1,699,000 | +65.6% | 42,428 | +32.2% | 0.00% | +50.0% |
| Q2 2015 | $1,026,000 | +294.6% | 32,101 | +194.5% | 0.00% | +100.0% |
| Q1 2015 | $260,000 | – | 10,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |